Dr. Magali Saint-Geniez received her PhD degree from the University of Toulouse, France, where she trained in vascular research at the ISERM laboratory. Dr. Saint-Geniez joined the Schepens Eye Research Institute of Massachusetts Eye and Ear Infirmary in 2002 to complete her post-doctoral training in the laboratory of Dr. Patricia D’Amore, where she studied the role of vascular endothelial growth factor in ocular development and maintenance of retinal homeostasis. She is now an assistant scientist at the Schepens Eye Research Institute and assistant professor in the Department of Ophthalmology, Harvard Medical School. Her current research program focuses on characterizing novel molecular pathways involved in common retinal degenerative diseases, such as AMD. In particular, she is investigating the underlying pathogenic roles of metabolic dysfunction and oxidative damage in photoreceptors and RPE, and is evaluating the therapeutic benefits of novel metabolic regulators using multidisciplinary approaches, including bioengineering, molecular and metabolic biology of novel in vitro and in vivo disease models.
The Schepens Eye Research Institute, Harvard Medical School